Stock Comparison

REGN vs RVMD

Regeneron Pharmaceuticals Inc and Revolution Medicines Inc side by side — valuation, profitability, growth and risk.

REGN

Regeneron Pharmaceuticals Inc

Healthcare

RVMD

Revolution Medicines Inc

Healthcare

Valuation

Market Cap

$80.55B

$42.92B

P/E (TTM)

19.4

—

Forward P/E

17.1

—

Price/Sales

5.2

8,818.1

Price/Book

2.5

16.5

EV/EBITDA

13.1

-9.5

Dividend Yield

0.45%

—

Profitability

Net Margin

29.65%

0.00%

Operating Margin

24.32%

0.00%

Return on Equity

14.00%

-76.70%

Return on Assets

6.53%

-37.50%

Growth (YoY)

Revenue Growth

16.70%

-95.20%

Earnings Growth

-4.50%

0.00%

Price & Risk

Beta

0.2

1.4

52-Week High

$810.12

$206.97

52-Week Low

$553.38

$35.67

Analyst Target

$833.54

$213.66

Compare REGN and RVMD your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.